Swedish Orphan Biovitrum AB (BIOVF)
42.80
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Swedish Orphan Biovitrum Gross Profit Margin (Quarterly) : 61.17% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.17% |
| March 31, 2026 | 66.20% |
| December 31, 2025 | 71.47% |
| September 30, 2025 | -16.26% |
| June 30, 2025 | 63.61% |
| March 31, 2025 | 62.88% |
| December 31, 2024 | 66.04% |
| September 30, 2024 | 68.45% |
| June 30, 2024 | 60.51% |
| March 31, 2024 | 61.89% |
| December 31, 2023 | 65.15% |
| September 30, 2023 | 60.08% |
| June 30, 2023 | 59.61% |
| March 31, 2023 | 67.68% |
| December 31, 2022 | 69.17% |
| September 30, 2022 | 63.12% |
| June 30, 2022 | 60.32% |
| March 31, 2022 | 66.09% |
| December 31, 2021 | 69.51% |
| September 30, 2021 | 62.30% |
| June 30, 2021 | 61.48% |
| March 31, 2021 | 67.88% |
| December 31, 2020 | 71.12% |
| September 30, 2020 | 62.93% |
| June 30, 2020 | 62.02% |
| Date | Value |
|---|---|
| March 31, 2020 | 67.30% |
| December 31, 2019 | 69.90% |
| September 30, 2019 | 62.39% |
| June 30, 2019 | 64.94% |
| March 31, 2019 | 67.75% |
| December 31, 2018 | 69.19% |
| September 30, 2018 | 70.32% |
| June 30, 2018 | 68.41% |
| March 31, 2018 | 66.24% |
| December 31, 2017 | 65.44% |
| September 30, 2017 | 63.65% |
| June 30, 2017 | 64.31% |
| March 31, 2017 | 64.90% |
| December 31, 2016 | 58.05% |
| September 30, 2016 | 57.39% |
| June 30, 2016 | 65.90% |
| March 31, 2016 | 66.93% |
| December 31, 2015 | 55.04% |
| September 30, 2015 | 52.67% |
| June 30, 2015 | 53.66% |
| March 31, 2015 | 51.79% |
| December 31, 2014 | 50.43% |
| September 30, 2014 | 48.82% |
| June 30, 2014 | 50.70% |
| March 31, 2014 | 43.52% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hansa Biopharma AB | 53.57% |
| BioArctic AB | 91.24% |
| Diamyd Medical AB | -32.07K% |
| BONESUPPORT HOLDING AB | 90.81% |
| BioInvent International AB | 0.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.76% |
| Return on Assets | 2.00% |
| Return on Invested Capital | 2.73% |
| Profit Margin (Quarterly) | 14.00% |
| Operating Margin (Quarterly) | 24.06% |
| Return on Net Operating Assets | 2.16% |